Insider Transactions in Q1 2023 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,729
-2.1%
|
$139,664
$16.81 P/Share
|
|
Jan 27
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,600
-0.38%
|
$36,800
$23.52 P/Share
|
|
Jan 26
2023
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
300
-0.07%
|
$6,900
$23.56 P/Share
|
|
Jan 23
2023
|
Dimitry Sa Nuyten Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+30.77%
|
-
|
|
Jan 23
2023
|
Juan C. Jaen President |
BUY
Grant, award, or other acquisition
|
Direct |
45,800
+12.36%
|
-
|
|
Jan 23
2023
|
Jennifer Jarrett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,800
+9.9%
|
-
|
|
Jan 23
2023
|
Carolyn C. Tang General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+25.85%
|
-
|
|
Jan 23
2023
|
Ii Robert C. Goeltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+34.89%
|
-
|
|
Jan 23
2023
|
Terry J Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,700
+18.39%
|
-
|